← Back to news

Markets

UBS Keeps Buy Rating on EQT Corporation (EQT)

Y

Morgan Stanley Keeps Equal Weight Rating on VICI Properties (VICI)

Y

Netflix (NFLX): The Worst Blue Chip Stock to Buy Now

Y

3 Covered Call ETFs to Buy for Monthly Income in 2026

Y

Andy Jassy Says This Could Be a $50 Billion Business for Amazon

Y

I’m 61 Years Old With $200,000 Saved for Retirement. What’s My Game Plan?

Y

A Workday Insider Sold Company Shares for $131,000. Here's What That Means for Investors.

Y

Forget Oil Prices — This 1 Refining Number Explains Why These Energy Stocks Are On Fire

Y

Jim Cramer crowns one surging sector the hottest in the market

Y

Heartland Value Fund’s Views on Photronics (PLAB)

Y

Will I3 Verticals (IIIV) Benefit From AI?

Y

Nvidia Stock Nears Buy Point On These Positive Signs

Y

SK Hynix Drops 5%, SanDisk Slides 6%, Western Digital Slips 4% as Traders Take Profits in Memory Stocks

Y

Here are the Compelling Reasons to Add Sonic Automotive (SAH)

Y

Bank of Canada holds rates, says economy is growing again

Y

BlackRock beats profit estimates on record inflows

Y

Texas Roadhouse is Reportedly Testing the First-Party Delivery Waters

Y

He Took an $18,000 Pay Cut Just to Get Back to Work. Here’s What It Actually Does to His Social Security.

Y

Cogent Bioscience (COGT) Files New Drug Application For Bezuclastinib

Y

Tango Therapeutics (TNGX) to Benefit From Vopimetostat + KRAS Inhibitors Combined Revenues

Y

Bank of America Securities Maintains Buy Rating for Beam Therapeutics (BEAM)

Y

Palvella Therapeutics (PVLA) Submits Initial Module of NDA For QTORIN

Y

Dyne Therapeutics (DYN) Inspires Confidence With Its Force Platform

Y

Lumvoa’s Unique Profile Leads to Optimism Around Viridian Therapeutics (VRDN)

Y

Praxis Precision Medicines (PRAX) Enters Into Licensing and Research Collaboration With Remagine Labs

Y

Taysha Gene Therapies (TSHA) is One of The Most Affordable Biotech Names to Invest In

Y

Vertex to Acquire Crinetics Pharmaceuticals (CRNX) in $85 Per Share Cash Deal

Y

Walmart vs Johnson & Johnson: Two Defensive Plays, Diverging Strategies and One Winner

Y

KPMG Australia considers job cuts amid audit leaks scandal – report

Y

What Makes Unitil (UTL) an Investment Opportunity Beyond the Technology Sector?

Y

A Buffett Superfan Paid $50,000 for a Signed Book, More Than the ‘Oracle’ Paid for His Whole House

Y

NYC’s housing crisis hits ‘DEFCON 1,’ comptroller warns as rents surge to record highs — is Mamdani’s plan working?

Y

Wall Street Thinks Chemours Company (CC) Is Too Cheap To Ignore Now

Y

Oakmark Global Fund Bets on Owens Corning’s (OC) Dominant Market Position in Roofing

Y

Fed Chairman Kevin Warsh's testimony to Senate banking committee hits on economy, interest rates

F

Phillips 66 (PSX) Investors Should Brace For Volatility Amid Cheap Valuation

Y

Dana Inc (DAN) Is Building A Bigger Auto Parts Business. Here’s Why Its A Good Buy

Y

Halozyne Therapeutics (HALO) Is An Undervalued Stock That Keeps Winning In Cancer Treatment

Y

Here’s Why Happen Inc’s (HAPN) Rebranding Could Mean More Than Investors Think

Y

UWM Holdings (UWMC) Stock Has Room To Run Due To Cheap Valuation

Y

Wall Street Thinks Alaska Air (ALK) Could Outperform Over The Next Year

Y

Antero Resources’ (AR) Current Valuation Makes It A Top Growth Stock To Buy For Next 10 Years

Y

‘Arsenal of democracy’: Jamie Dimon announces $24 million effort to boost American shipbuilding

F

James Watt bids to buy back BrewDog

Y

Strategy Says It’s ‘Secure’ Until Bitcoin Falls Below $10,000

Y

Pullback Created an Attractive Entry Point in The Cooper Companies (COO)

Y

One chart reveals why investors are concerned about earnings from Microsoft, Amazon, and other hyperscalers

Y

ASML shares rise after Q2 earnings beat estimates, company raises 2026 outlook

Y

Oracle Cratered Again. Shares Might Be a Triple If These Analysts Are Right.

Y

IBM downgraded, Cava upgraded: Wall Street's top analyst calls

Y